Your browser doesn't support javascript.
loading
Bacterial extracellular vesicles: Understanding biology promotes applications as nanopharmaceuticals.
Jahromi, Leila Pourtalebi; Fuhrmann, Gregor.
Afiliação
  • Jahromi LP; Biogenic Nanotherapeutics Group (BION), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Campus E8.1, Saarbrücken 66123, Germany; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany. Electronic address: leila.pourtalebi@helmholtz-hips.de.
  • Fuhrmann G; Biogenic Nanotherapeutics Group (BION), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Campus E8.1, Saarbrücken 66123, Germany; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany. Electronic address: gregor.fuhrmann@helmholtz-hips.de.
Adv Drug Deliv Rev ; 173: 125-140, 2021 06.
Article em En | MEDLINE | ID: mdl-33774113
ABSTRACT
Extracellular vesicle (EV)-mediated communication between proximal and distant cells is a highly conserved characteristic in all of the life domains, including bacteria. These vesicles that contain a variety of biomolecules, such as proteins, lipids, nucleic acids, and small-molecule metabolites play a key role in the biology of bacteria. They are one of the key underlying mechanisms behind harmful or beneficial effects of many pathogenic, symbiont, and probiotic bacteria. These nanoscale EVs mediate extensive crosstalk with mammalian cells and deliver their cargos to the host. They are stable in physiological condition, can encapsulate diverse biomolecules and nanoparticles, and their surface could be engineered with available technologies. Based on favorable characteristics of bacterial vesicles, they can be harnessed for designing a diverse range of therapeutics and diagnostics for treatment of disorders including tumors and resistant infections. However, technical limitations for their production, purification, and characterization must be addressed in future studies.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Bactérias / Nanopartículas / Vesículas Extracelulares Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Bactérias / Nanopartículas / Vesículas Extracelulares Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article